Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 90,732 | 20,531 | 31,937 | 13,728 | 6,053 |
| Gross Profit | 90,732 | 20,531 | 31,937 | 13,728 | 6,053 |
| Operating Expenses | 225,572 | 161,453 | 145,664 | 133,661 | 103,241 |
| Operating Income | -134,840 | -140,922 | -113,727 | -119,933 | -97,188 |
| Interest Expense | -16,259 | 137 | -328 | 978 | -62 |
| Other Income | 2,605 | 7,313 | 3,445 | 587 | -57 |
| Pre-tax Income | -115,976 | -133,746 | -109,954 | -120,324 | -97,183 |
| Net Income Continuous | -115,976 | -133,746 | -109,954 | -120,324 | -97,183 |
| Net Income | $-115,976 | $-133,746 | $-109,954 | $-120,324 | $-97,183 |
| EPS Basic Total Ops | -1.98 | -2.68 | -2.33 | -2.98 | -3.02 |
| EPS Basic Continuous Ops | -1.98 | -2.68 | -2.33 | -2.98 | -3.02 |
| EPS Diluted Total Ops | -1.98 | -2.68 | -2.33 | -2.98 | -3.02 |
| EPS Diluted Continuous Ops | -1.98 | -2.68 | -2.33 | -2.98 | -3.02 |
| EPS Diluted Before Non-Recurring Items | -1.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-130,881 | $-138,092 | $-110,473 | $-117,250 | $-95,986 |